SKIN
SkinHealth Systems Inc.
$0.73
Platform & Compounding FCF
85%
Two-stage FCF DCF
Strong
·
Conviction
Undervalued
Trading 50.1% below fair value
You pay
$0.73
Bear
$1.47
Fair
$1.47
Bull
$1.65
Bear
$1.47
+100.5%
3% stage 1 growth, 11% discount
Fair
$1.47
+100.5%
3% stage 1 growth, 11% discount
Bull
$1.65
+125.2%
4% stage 1 growth, 11% discount
Key Value Driver
FCF growth rate (3% base case)
Terminal Value % of EV
33%
Implied Market Multiple
9.2x
Market is pricing in (growth)
-1.7%
vs 3.0% base
Summary
Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $1.50 from 14 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $1.47 per share.
Key Risks
- P/E alone misleads — earnings depressed by growth investment
- Cyclical or commodity businesses may be misclassified as platforms
- Terminal value dominance suggests sensitivity to long-run assumptions